title: Effects of Ginger on Serum Lipids and Lipoproteins in Peritoneal Dialysis Patients: A Randomized Controlled Trial.
abstract: ♦
  
  
  BACKGROUND
  In peritoneal dialysis (PD) patients, one of the major risk factors for cardiovascular disease is lipid abnormalities. This study was designed to investigate the effects of ginger supplementation on serum lipids and lipoproteins in PD patients. ♦
  
  
  METHODS
  In this randomized, double-blind, placebo-controlled trial, 36 PD patients were randomly assigned to either the ginger or the placebo group. The patients in the ginger group received 1,000 mg ginger daily for 10 weeks, while the placebo group received corresponding placebos. At baseline and at the end of week 10, 7 mL of blood were obtained from each patient after a 12- to 14-hour fast, and serum concentrations of triglyceride, total cholesterol, low density lipoprotein-cholesterol (LDL-C), high density lipoprotein-cholesterol (HDL-C), and lipoprotein (a) [Lp (a)] were measured. ♦
  
  
  RESULTS
  Serum triglyceride concentration decreased significantly up to 15% in the ginger group at the end of week 10 compared with baseline (p < 0.01), and the reduction was significant in comparison with the placebo group (p < 0.05). There were no significant differences between the 2 groups in mean changes of serum total cholesterol, LDL-C, HDL-C, and Lp (a). ♦
  
  
  CONCLUSIONS
  This study indicates that daily administration of 1,000 mg ginger reduces serum triglyceride concentration, which is a risk factor for cardiovascular disease, in PD patients.
authors.affiliation: Department of Clinical Nutrition & Dietetics, Faculty of Nutrition and Food Technology, National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, Tehran, Islamic Republic of Iran hadtabibi@yahoo.com.
authors.forename: Hadi
authors.initials: H
authors.lastname: Tabibi
authors.affiliation: Faculty of Nutrition and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Islamic Republic of Iran.
authors.forename: Hossein
authors.initials: H
authors.lastname: Imani
authors.affiliation: Department of Nephrology, Shahid Beheshti University of Medical Sciences, Tehran, Islamic Republic of Iran.
authors.forename: Shahnaz
authors.initials: S
authors.lastname: Atabak
authors.affiliation: Department of Nephrology, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran.
authors.forename: Iraj
authors.initials: I
authors.lastname: Najafi
authors.affiliation: Cellular and Molecular Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Islamic Republic of Iran.
authors.forename: Mehdi
authors.initials: M
authors.lastname: Hedayati
authors.affiliation: Shafa Clinic, Tehran, Islamic Republic of Iran.
authors.forename: Leila
authors.initials: L
authors.lastname: Rahmani
mesh_terms: D000328:Adult; D000368:Aged; D019587:Dietary Supplements; D004311:Double-Blind Method; D005260:Female; D020939:Zingiber officinale / Q000737:chemistry*; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy* / Q000209:etiology; D007492:Iran; D007676:Kidney Failure, Chronic / Q000628:therapy; D008055:Lipids / Q000097:blood*; D008074:Lipoproteins / Q000097:blood* / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D010530:Peritoneal Dialysis; D012042:Registries
chemical_list: D008055:Lipids; D008074:Lipoproteins
keywords: Ginger; cardiovascular disease; lipids; lipoproteins; peritoneal dialysis